Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers
Open Access
Abstract
Nuclear factor erythroid 2–related factor 2 (Nrf2) is a transcription factor that plays a central role in regulating cellular responses to oxidative stress. It governs the expression of a broad range of genes involved in antioxidant defense, detoxification, metabolism, and other cytoprotective pathways. In normal cells, the transient activation of Nrf2 serves as a protective mechanism to maintain redox homeostasis. However, the persistent or aberrant activation of Nrf2 in cancer cells has been implicated in tumor progression, metabolic reprogramming, and resistance to chemotherapy and radiotherapy. These dual roles underscore the complexity of Nrf2 signaling and its potential as a therapeutic target. A deeper understanding of Nrf2 regulation in both normal and malignant contexts is essential for the development of effective Nrf2-targeted therapies. This review provides a comprehensive overview of Nrf2 regulation and function, highlighting its unique features in cancer biology, particularly its role in metabolic adaptation and drug resistance. Special attention is given to the current knowledge of Nrf2′s involvement in leukemia and emerging strategies for its therapeutic modulation.Keywords
Funding Information
- AIRC (30924, 1/3(7)/2020/TMC/R&D-II/8823)
- Department of Atomic Energy (DAE) (30924, 1/3(7)/2020/TMC/R&D-II/8823)
This publication has 210 references indexed in Scilit:
- An insight into role of amino acids as antioxidants via NRF2 activationAmino Acids, 2024
- Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitateBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2023
- PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stabilityImmunity, Inflammation and Disease, 2021
- Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathwayApoptosis, 2019
- A cellular perspective of adipogenesis transcriptional regulationJournal of Cellular Physiology, 2018
- Nrf2 regulates ROS production by mitochondria and NADPH oxidaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2015
- Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense responseMolecular Carcinogenesis, 2012
- The cytoprotective role of the Keap1–Nrf2 pathwayArchives of Toxicology, 2011
- Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elementsArchives of Biochemistry and Biophysics, 2008
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissuesBiochemical and Biophysical Research Communications, 2008